ATE330029T1 - Bestimmung der prädisposition für obstruktive lungenerkrankung basierend auf genpolymorphismen der humanen luftweg-trypsin-protease - Google Patents

Bestimmung der prädisposition für obstruktive lungenerkrankung basierend auf genpolymorphismen der humanen luftweg-trypsin-protease

Info

Publication number
ATE330029T1
ATE330029T1 AT98961367T AT98961367T ATE330029T1 AT E330029 T1 ATE330029 T1 AT E330029T1 AT 98961367 T AT98961367 T AT 98961367T AT 98961367 T AT98961367 T AT 98961367T AT E330029 T1 ATE330029 T1 AT E330029T1
Authority
AT
Austria
Prior art keywords
prediposition
determination
lung disease
protease gene
disease based
Prior art date
Application number
AT98961367T
Other languages
English (en)
Inventor
Hiroshi Eguchi
Kazuyoshi Yamaoka
Kenichi Masuda
Susumu Yasuoka
Original Assignee
Teijin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teijin Ltd filed Critical Teijin Ltd
Application granted granted Critical
Publication of ATE330029T1 publication Critical patent/ATE330029T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6427—Chymotrypsins (3.4.21.1; 3.4.21.2); Trypsin (3.4.21.4)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT98961367T 1997-12-16 1998-12-16 Bestimmung der prädisposition für obstruktive lungenerkrankung basierend auf genpolymorphismen der humanen luftweg-trypsin-protease ATE330029T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP34649497 1997-12-16

Publications (1)

Publication Number Publication Date
ATE330029T1 true ATE330029T1 (de) 2006-07-15

Family

ID=18383814

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98961367T ATE330029T1 (de) 1997-12-16 1998-12-16 Bestimmung der prädisposition für obstruktive lungenerkrankung basierend auf genpolymorphismen der humanen luftweg-trypsin-protease

Country Status (11)

Country Link
US (1) US6346385B1 (de)
EP (1) EP1043406B1 (de)
JP (1) JP4031199B2 (de)
KR (1) KR100502523B1 (de)
CN (1) CN1222615C (de)
AT (1) ATE330029T1 (de)
AU (1) AU747991B2 (de)
CA (1) CA2315218C (de)
DE (1) DE69834949T8 (de)
ES (1) ES2263228T3 (de)
WO (1) WO1999031271A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1314779B1 (de) * 2000-08-28 2007-10-03 Teijin Limited Atemwegspezifische, trypsin-ähnliche enzyme und verfahren zu deren anwendung
WO2002050277A2 (en) * 2000-12-21 2002-06-27 Curagen Corporation Protein and nucleic acids encoding same
US6596489B2 (en) 2001-03-30 2003-07-22 Applied Gene Technologies Methods and compositions for analyzing nucleotide sequence mismatches using RNase H
GB0113266D0 (en) * 2001-05-31 2001-07-25 Bayer Ag Genes and proteins for prevention prediction diagnosis prognosis and treatment of chronic lung disease
WO2002099134A1 (en) * 2001-06-05 2002-12-12 Auckland Uniservices Limited Methods and compositions for assessment of pulmonary function and disorders
AU2002364945A1 (en) * 2001-10-25 2003-07-09 Neurogenetics, Inc. Genes and polymorphisms on chromosome 10 associated with alzheimer's disease and other neurodegenerative diseases
US20030224380A1 (en) * 2001-10-25 2003-12-04 The General Hospital Corporation Genes and polymorphisms on chromosome 10 associated with Alzheimer's disease and other neurodegenerative diseases
DE10258051A1 (de) * 2002-12-11 2004-07-22 Metagen Pharmaceuticals Gmbh Verwendung von an HAT bindenden Substanzen zur Diagnose und Behandlung des Plattenepithelkarzinoms der Lunge
EP1896607A4 (de) * 2005-05-10 2009-12-16 Synergenz Bioscience Ltd Verfahren und zusammensetzungen zur beurteilung der lungenfunktion und von lungenerkrankungen
JP2008545390A (ja) * 2005-05-19 2008-12-18 シナージェンズ バイオサイエンス リミティド 遺伝的多型を用いた肺癌を発達させるリスクの評価方法
WO2006123943A1 (en) * 2005-05-20 2006-11-23 Synergenz Bioscience Limited Methods of analysis of polymorphisms and uses thereof
ES2437240B1 (es) * 2012-06-05 2014-10-16 Servicio Andaluz De Salud Método de obtención de datos útiles para el diagnóstico, pronóstico y clasificación de los pacientes con enfermedad pulmonar obstructiva crónica (EPOC) y/o cáncer de pulmón

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2839825B2 (ja) * 1993-08-30 1998-12-16 帝人株式会社 新規トリプシン様酵素
JP3512486B2 (ja) * 1994-09-27 2004-03-29 株式会社中埜酢店 しゃぶしゃぶ用濃縮胡麻垂れ

Also Published As

Publication number Publication date
KR100502523B1 (ko) 2005-07-20
AU747991B2 (en) 2002-05-30
AU1682399A (en) 1999-07-05
HK1032077A1 (en) 2001-07-06
ES2263228T3 (es) 2006-12-01
CN1222615C (zh) 2005-10-12
DE69834949T2 (de) 2007-05-24
DE69834949T8 (de) 2008-10-09
CA2315218A1 (en) 1999-06-24
CN1285002A (zh) 2001-02-21
KR20010033207A (ko) 2001-04-25
JP4031199B2 (ja) 2008-01-09
EP1043406A1 (de) 2000-10-11
CA2315218C (en) 2007-03-20
EP1043406A4 (de) 2002-11-04
WO1999031271A1 (fr) 1999-06-24
DE69834949D1 (de) 2006-07-27
EP1043406B1 (de) 2006-06-14
US6346385B1 (en) 2002-02-12

Similar Documents

Publication Publication Date Title
Woolley et al. Small molecular weight β1 serum protein which specifically inhibits human collagenases
DE69834949T8 (de) Bestimmung der prädisposition für obstruktive lungenerkrankung basierend auf genpolymorphismen der humanen luftweg-trypsin-protease
Hess et al. Weekly ventilator circuit changes: a strategy to reduce costs without affecting pneumonia rates
DK1984006T3 (da) Konditioneret blodsammensætning og fremgangsmåde til produktion deraf
NO20044436L (no) Substituerte fenyleddiksyrer
WO2004046729A3 (en) Bodily fluid markers of tissue hypoxia
SE0401208D0 (sv) Multilevel ventilator
ATE444073T1 (de) Oxalate-abbauende mikroorganismen oder oxalate- abbauende enzyme zur verhütung der oxalate- verwandten krankheiten
ATE450622T1 (de) Gene und proteine für verhinderung, vorhersage, prognose und therapie der herzgefäss-krankheit
DE69533914D1 (de) Anordnung zum Behandlen von Krankheiten
EP1474438A4 (de) Verfahren zur herstellung eines gereinigten rekombinanten humanen uteroglobins zur behandlung von entzündlichen und fibrotischen erkrankungen
WO2001004349A3 (en) Method for the diagnosis or the prognosis of alzheimer disease therapeutical composition for preventing or treating alzheimer disease
Fuschillo et al. Nocturnal mechanical ventilation improves exercise capacity in kyphoscoliotic patients with respiratory impairment.
Yanamandra et al. Novel allele of the endothelial nitric oxide synthase gene polymorphism in Caucasian asthmatics
Patton et al. Cutis laxa and the Costello syndrome
Grilo et al. Genetic analysis of candidate SNPs for metabolic syndrome in obstructive sleep apnea (OSA)
Körber et al. Endotracheal complications after long-term ventilation. Noninvasive ventilation in chronic thoracic diseases as an alternative to tracheostomy
CN109161590B (zh) 整合素β4基因DNA甲基化位点在制备哮喘和或COPD早期诊断的生物标志物的应用
WO2002097127A3 (en) Genes and proteins for prevention, prediction, diagnosis, prognosis and treatment of chronic lung disease
WO2002010403A3 (en) Regulation of human phosphatidylinositol-specific phospholipase c-like enzyme
PL340624A1 (en) Preparations and drugs for treating chronic obstruction of respiratory tracts
ATE374260T1 (de) Asthma-assoziiertes gen
DE60229920D1 (de) Marker für Lungentumore
SU1672362A1 (ru) Способ прогнозировани прогрессирующего хронического воспалительного процесса в легких
WO2005118845A3 (de) Verwendung einer genveränderung im humanen gnaq-gen zur vorhersage von erkrankungsrisiken, krankheitsverläufen und zur vorhersage des ansprechens auf krankheitstherapien

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1043406

Country of ref document: EP